Aim & Scope
The World Journal of Diabetes Research and Practice ((3065-5161) is committed to advancing global knowledge and clinical practice surrounding diabetes mellitus and related metabolic disorders. As a specialized forum for scholarly communication, the journal aims to bridge the scientific, clinical, and policy-related aspects of diabetes care. We support original and high-quality publications that explore both fundamental mechanisms of disease and practical applications in the management and treatment of diabetes across populations and healthcare systems.
Aims of the Journal
The primary aim of the journal is to serve as a central resource for researchers, healthcare professionals, and policy advocates working within the field of diabetology and endocrine disorders. Through timely and relevant publications, the journal fosters a deeper understanding of the biological, behavioral, environmental, and social factors that contribute to the onset and progression of diabetes.
We aim to:
Encourage publication of studies that improve diagnostic, therapeutic, and preventive strategies in the care of individuals with diabetes.
Provide a platform for translating scientific discoveries into actionable interventions for clinical and public health settings.
Support interdisciplinary collaboration between endocrinologists, general practitioners, nutritionists, diabetes educators, epidemiologists, and biomedical researchers.
Promote research that enhances patient outcomes, reduces diabetes-related complications, and supports better quality of life for people living with chronic metabolic conditions.
Scope of the Journal
The scope of the World Journal of Diabetes Research and Practice encompasses a wide range of scientific domains that intersect with diabetes, metabolic dysfunction, and chronic disease management. We invite contributions that address the cellular and molecular biology of diabetes, as well as those that focus on clinical management, public health initiatives, health policy, and behavioral sciences.
The journal welcomes submissions in, but not limited to, the following core areas:
Basic and Translational Research
Molecular and genetic mechanisms involved in insulin secretion and action
Inflammatory pathways contributing to insulin resistance and beta-cell dysfunction
Autoimmunity in type 1 diabetes and new targets for immunomodulation
Animal models of diabetes for translational application
Discovery of new biomarkers for early detection and treatment monitoring
Clinical Research and Therapeutics
Clinical trials testing the efficacy of antidiabetic medications, insulin therapies, and combination treatments
Comparative studies on type 1 and type 2 diabetes management
Advances in pharmacologic agents, including DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
Use of medical devices such as continuous glucose monitoring systems and insulin pumps
Patient-centered approaches to long-term diabetes management and adherence
Epidemiology and Risk Stratification
Population-based studies on diabetes incidence, prevalence, and disease burden
Analysis of geographic, ethnic, and socioeconomic disparities in diabetes care
Risk factor modeling for type 2 diabetes in adult and pediatric populations
Studies examining genetic predisposition and environmental triggers
Longitudinal cohort studies and registry data on diabetes progression and complications
Prevention and Lifestyle Interventions
Lifestyle modification strategies including dietary planning, physical activity, and behavioral counseling
Community-based intervention studies promoting early detection and health literacy
Diabetes prevention programs targeting high-risk groups such as individuals with prediabetes
School-based and workplace programs focused on diabetes awareness and control
Role of bariatric surgery and medical nutrition therapy in diabetes prevention
Complications and Comorbidities
Diabetic nephropathy, retinopathy, neuropathy, and associated clinical pathways
Cardiovascular disease in diabetic populations and strategies for risk reduction
Mental health issues in diabetes such as depression and diabetes-related distress
Diabetic foot care and limb preservation practices
Management of chronic kidney disease and liver disease in individuals with diabetes
Health Systems, Technology, and Public Health
Implementation of electronic health records and telemedicine in diabetes care
Integration of artificial intelligence and digital tools in patient monitoring
Policy analyses and health system evaluations for diabetes program planning
Health economics, cost-effectiveness analyses, and resource utilization studies
Mobile health applications and digital therapeutics for self-care management
Types of Manuscripts Accepted
The World Journal of Diabetes Research and Practice publishes a diverse array of manuscript types. Authors are encouraged to submit:
Original research articles presenting novel findings
Clinical studies and randomized controlled trials
Systematic reviews and meta-analyses that synthesize current evidence
Short communications reporting significant preliminary data
Case reports highlighting rare presentations or novel treatment approaches
Methodological articles describing innovative tools or experimental models
Editorials, viewpoints, and expert commentaries on current issues and controversies
Public health reports and policy discussions relevant to diabetes care
By accepting a broad spectrum of article types, the journal facilitates meaningful dialogue among laboratory scientists, clinical investigators, healthcare administrators, educators, and decision-makers.
A Platform for Global Diabetes Knowledge
The World Journal of Diabetes Research and Practice recognizes the urgent need to disseminate research from both high-resource and resource-limited settings. We encourage submissions that examine region-specific challenges, culturally sensitive approaches, and health systems research addressing barriers to care.
Through the publication of inclusive and globally relevant research, the journal strives to contribute to a deeper understanding of diabetes in all its forms and manifestations. Our goal is to improve health outcomes, reduce complications, and enhance the well-being of individuals and communities affected by diabetes around the world.
